한글목차

세계의 EVA 주입백 시장 규모는 2024년에 2억 9,200만 달러로 추정되며, 2025-2031년의 예측 기간에 CAGR 6.0%로 성장하여 2031년까지 4억 3,700만 달러로 확대될 것으로 예측됩니다.

본 보고서는 EVA 주입백에 대한 최근 관세 조정과 국제적인 전략적 대응 조치에 대해 국경 간 산업적 발자취, 자본 배분 패턴, 지역 경제의 상호 의존성, 공급망 재구축 등의 관점에서 종합적인 평가를 제공합니다.

EVA 주입백은 무균 일회용 의료기기로 비경구 용액의 준비, 보관 및 투여에 사용됩니다. 일반적으로 PVC 프리, DEHP 프리, 라텍스 프리, EVA 소재로 제조됩니다. 무균 용액의 사용기한(BUD)을 연장하고, 추가 성분(지질 등)을 다른 용기로 옮길 수 있도록 하기 위해 EVA 주입백은 종종 단일 챔버 또는 다중 챔버 구조로 제공됩니다.

EVA 주입백의 세계 주요 제조업체로는 Baxter International, B. Braun, Fresenius Kabi, Weigao Group, ICU Medical 등이 있습니다. 상위 5개사의 점유율은 약 64%를 차지하고 있습니다.

북미는 EVA 주입백의 주요 소비 지역으로 전체 매출의 약 40%를 차지하고 있습니다. 그 다음으로 아시아태평양(APAC)이 32%의 소비 시장 점유율을 차지하고 있습니다. 아시아태평양의 EVA 주입백 시장은 2024 년에 다시 한 번 큰 성장을 이루었습니다. 이는 주로 고령화 사회의 진전, 생활수준의 향상, 이에 따른 건강 의식 증가가 주요 요인으로 작용하고 있습니다. 중국은 세계에서 가장 많은 인구를 가진 나라로 노인 인구 비율이 빠르게 증가하고 있습니다. 이러한 인구 구조적 과제에 대응하기 위해, 이 나라의 의료 시스템은 수년 동안 확장 및 개편이 진행되어 왔습니다.

제품 유형별로는 멀티챔버가 가장 큰 비중을 차지하며 51%의 점유율을 차지하고 있습니다. 용도별로는 병원이 가장 큰 용도 분야로 61%의 점유율을 차지하고 있습니다.

의료 분야에서 첨단 약물 전달 시스템에 대한 수요가 증가하고 있습니다. EVA 주입백은 기존 PVC(폴리염화비닐) 백에 비해 유해 화학물질의 용출 위험이 낮고, 유연성이 뛰어나며, 다양한 약제와 호환되는 등 여러 가지 장점을 제공합니다. 의료진과 제약회사가 환자의 안전과 약효를 우선시하는 가운데, EVA 주입백의 채택이 증가하고 있습니다. 또한, 의료기기에 보다 안전하고 호환성이 높은 재료의 사용을 권장하는 규제 동향도 EVA 주입백 시장 성장에 기여하고 있습니다.

이 보고서는 EVA 주입백 세계 시장에 대해 총 판매량, 매출, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역/국가, 유형 및 용도별 분석을 종합적으로 제시하는 것을 목표로 합니다.

이 보고서는 2024년을 기준 연도로 하여 2020-2031년의 과거 데이터와 예측 데이터를 포함하여 판매량(천 단위) 및 매출액(백만 달러)으로 EVA 주입백 시장 규모, 추정 및 예측을 제시합니다. 정량적 분석과 정성적 분석을 통해 독자들이 EVA 주입백 관련 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 도와드립니다.

시장 세분화

기업별

• Baxter International
• B. Braun
• Fresenius Kabi
• Weigao Group
• ICU Medical
• Metrix
• Technoflex
• Bexen Medical
• Eraser Medical
• Valmed
• Kapsam Health Products
• Hemedis
• Velfor Group
• Merit Pharmaceutical

유형별 부문

• 싱글 챔버
• 멀티 챔버

용도별 부문

• 병원
• 진료소
• 기타

지역별

• 북미
  • 미국
  • 캐나다
• 아시아태평양
  • 중국
  • 일본
  • 한국
  • 동남아시아
  • 인도
  • 호주
  • 기타 아시아태평양
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 네덜란드
  • 북유럽 국가
  • 기타 유럽
• 라틴아메리카
  • 멕시코
  • 브라질
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 튀르키예
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동 및 아프리카

영문목차

The global market for EVA Infusion Bags was estimated to be worth US$ 292 million in 2024 and is forecast to a readjusted size of US$ 437 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on EVA Infusion Bags cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

EVA Infusion Bags are sterile, single-use medical devices that are used for the preparation, preservation and administration of parenteral solutions. They are usually made from PVC-free, DEHP-free and latex-free EVA material. In order to enable transferring additional ingredients (such as lipids) into a separate container to extend the beyond-use date (BUD) of the sterile solution, EVA Infusion Bags often come up with the form of single-chamber or multi-chambers.

Global key players of EVA Infusion Bags include Baxter International, B. Braun, Fresenius Kabi, Weigao Group, ICU Medical, etc. The top five players hold a share about 64%.

North America is the dominate consumption region of EVA Infusion Bags, accounting for about 40% of the total revenue, followed by APAC, with the consumption market share of 32%. EVA Infusion bag in the Asia-Pacific region once again grew substantially in 2024, due predominantly to an aging population, growing prosperity and the associated increase in health awareness. China is the most populous country in the world, with a rapidly growing percentage of elderly people. In order to manage this demographic challenge, the country's health care system has been undergoing expansion and renovation for years.

In terms of product type, Multi-Chambers is the largest segment, occupied for a share of 51%. In terms of application, Hospital is the largest application, occupied for a share of 61%.

The growing demand for advanced drug delivery systems in healthcare. EVA infusion bags offer several advantages over traditional PVC (Polyvinyl Chloride) bags, including lower risk of leaching harmful chemicals, greater flexibility, and compatibility with a wider range of drugs. As healthcare providers and pharmaceutical companies prioritize patient safety and drug efficacy, the adoption of EVA infusion bags is increasing. Moreover, regulatory trends favoring the use of safer and more compatible materials in medical devices also contribute to the market growth of EVA infusion bags.

This report aims to provide a comprehensive presentation of the global market for EVA Infusion Bags, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of EVA Infusion Bags by region & country, by Type, and by Application.

The EVA Infusion Bags market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding EVA Infusion Bags.

Market Segmentation

By Company

• Baxter International
• B. Braun
• Fresenius Kabi
• Weigao Group
• ICU Medical
• Metrix
• Technoflex
• Bexen Medical
• Eraser Medical
• Valmed
• Kapsam Health Products
• Hemedis
• Velfor Group
• Merit Pharmaceutical

Segment by Type

• Single Chamber
• Multi Chamber

Segment by Application

• Hospital
• Clinic
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of EVA Infusion Bags manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of EVA Infusion Bags in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of EVA Infusion Bags in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 EVA Infusion Bags Product Introduction
• 1.2 Global EVA Infusion Bags Market Size Forecast
  • 1.2.1 Global EVA Infusion Bags Sales Value (2020-2031)
  • 1.2.2 Global EVA Infusion Bags Sales Volume (2020-2031)
  • 1.2.3 Global EVA Infusion Bags Sales Price (2020-2031)
• 1.3 EVA Infusion Bags Market Trends & Drivers
  • 1.3.1 EVA Infusion Bags Industry Trends
  • 1.3.2 EVA Infusion Bags Market Drivers & Opportunity
  • 1.3.3 EVA Infusion Bags Market Challenges
  • 1.3.4 EVA Infusion Bags Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global EVA Infusion Bags Players Revenue Ranking (2024)
• 2.2 Global EVA Infusion Bags Revenue by Company (2020-2025)
• 2.3 Global EVA Infusion Bags Players Sales Volume Ranking (2024)
• 2.4 Global EVA Infusion Bags Sales Volume by Company Players (2020-2025)
• 2.5 Global EVA Infusion Bags Average Price by Company (2020-2025)
• 2.6 Key Manufacturers EVA Infusion Bags Manufacturing Base and Headquarters
• 2.7 Key Manufacturers EVA Infusion Bags Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of EVA Infusion Bags
• 2.9 EVA Infusion Bags Market Competitive Analysis
  • 2.9.1 EVA Infusion Bags Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by EVA Infusion Bags Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EVA Infusion Bags as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Single Chamber
  • 3.1.2 Multi Chamber
• 3.2 Global EVA Infusion Bags Sales Value by Type
  • 3.2.1 Global EVA Infusion Bags Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global EVA Infusion Bags Sales Value, by Type (2020-2031)
  • 3.2.3 Global EVA Infusion Bags Sales Value, by Type (%) (2020-2031)
• 3.3 Global EVA Infusion Bags Sales Volume by Type
  • 3.3.1 Global EVA Infusion Bags Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global EVA Infusion Bags Sales Volume, by Type (2020-2031)
  • 3.3.3 Global EVA Infusion Bags Sales Volume, by Type (%) (2020-2031)
• 3.4 Global EVA Infusion Bags Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospital
  • 4.1.2 Clinic
  • 4.1.3 Others
• 4.2 Global EVA Infusion Bags Sales Value by Application
  • 4.2.1 Global EVA Infusion Bags Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global EVA Infusion Bags Sales Value, by Application (2020-2031)
  • 4.2.3 Global EVA Infusion Bags Sales Value, by Application (%) (2020-2031)
• 4.3 Global EVA Infusion Bags Sales Volume by Application
  • 4.3.1 Global EVA Infusion Bags Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global EVA Infusion Bags Sales Volume, by Application (2020-2031)
  • 4.3.3 Global EVA Infusion Bags Sales Volume, by Application (%) (2020-2031)
• 4.4 Global EVA Infusion Bags Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global EVA Infusion Bags Sales Value by Region
  • 5.1.1 Global EVA Infusion Bags Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global EVA Infusion Bags Sales Value by Region (2020-2025)
  • 5.1.3 Global EVA Infusion Bags Sales Value by Region (2026-2031)
  • 5.1.4 Global EVA Infusion Bags Sales Value by Region (%), (2020-2031)
• 5.2 Global EVA Infusion Bags Sales Volume by Region
  • 5.2.1 Global EVA Infusion Bags Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global EVA Infusion Bags Sales Volume by Region (2020-2025)
  • 5.2.3 Global EVA Infusion Bags Sales Volume by Region (2026-2031)
  • 5.2.4 Global EVA Infusion Bags Sales Volume by Region (%), (2020-2031)
• 5.3 Global EVA Infusion Bags Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America EVA Infusion Bags Sales Value, 2020-2031
  • 5.4.2 North America EVA Infusion Bags Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe EVA Infusion Bags Sales Value, 2020-2031
  • 5.5.2 Europe EVA Infusion Bags Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific EVA Infusion Bags Sales Value, 2020-2031
  • 5.6.2 Asia Pacific EVA Infusion Bags Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America EVA Infusion Bags Sales Value, 2020-2031
  • 5.7.2 South America EVA Infusion Bags Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa EVA Infusion Bags Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa EVA Infusion Bags Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions EVA Infusion Bags Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions EVA Infusion Bags Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions EVA Infusion Bags Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions EVA Infusion Bags Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States EVA Infusion Bags Sales Value, 2020-2031
  • 6.3.2 United States EVA Infusion Bags Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States EVA Infusion Bags Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe EVA Infusion Bags Sales Value, 2020-2031
  • 6.4.2 Europe EVA Infusion Bags Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe EVA Infusion Bags Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China EVA Infusion Bags Sales Value, 2020-2031
  • 6.5.2 China EVA Infusion Bags Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China EVA Infusion Bags Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan EVA Infusion Bags Sales Value, 2020-2031
  • 6.6.2 Japan EVA Infusion Bags Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan EVA Infusion Bags Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea EVA Infusion Bags Sales Value, 2020-2031
  • 6.7.2 South Korea EVA Infusion Bags Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea EVA Infusion Bags Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia EVA Infusion Bags Sales Value, 2020-2031
  • 6.8.2 Southeast Asia EVA Infusion Bags Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia EVA Infusion Bags Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India EVA Infusion Bags Sales Value, 2020-2031
  • 6.9.2 India EVA Infusion Bags Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India EVA Infusion Bags Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Baxter International
  • 7.1.1 Baxter International Company Information
  • 7.1.2 Baxter International Introduction and Business Overview
  • 7.1.3 Baxter International EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Baxter International EVA Infusion Bags Product Offerings
  • 7.1.5 Baxter International Recent Development
• 7.2 B. Braun
  • 7.2.1 B. Braun Company Information
  • 7.2.2 B. Braun Introduction and Business Overview
  • 7.2.3 B. Braun EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 B. Braun EVA Infusion Bags Product Offerings
  • 7.2.5 B. Braun Recent Development
• 7.3 Fresenius Kabi
  • 7.3.1 Fresenius Kabi Company Information
  • 7.3.2 Fresenius Kabi Introduction and Business Overview
  • 7.3.3 Fresenius Kabi EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Fresenius Kabi EVA Infusion Bags Product Offerings
  • 7.3.5 Fresenius Kabi Recent Development
• 7.4 Weigao Group
  • 7.4.1 Weigao Group Company Information
  • 7.4.2 Weigao Group Introduction and Business Overview
  • 7.4.3 Weigao Group EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Weigao Group EVA Infusion Bags Product Offerings
  • 7.4.5 Weigao Group Recent Development
• 7.5 ICU Medical
  • 7.5.1 ICU Medical Company Information
  • 7.5.2 ICU Medical Introduction and Business Overview
  • 7.5.3 ICU Medical EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 ICU Medical EVA Infusion Bags Product Offerings
  • 7.5.5 ICU Medical Recent Development
• 7.6 Metrix
  • 7.6.1 Metrix Company Information
  • 7.6.2 Metrix Introduction and Business Overview
  • 7.6.3 Metrix EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Metrix EVA Infusion Bags Product Offerings
  • 7.6.5 Metrix Recent Development
• 7.7 Technoflex
  • 7.7.1 Technoflex Company Information
  • 7.7.2 Technoflex Introduction and Business Overview
  • 7.7.3 Technoflex EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Technoflex EVA Infusion Bags Product Offerings
  • 7.7.5 Technoflex Recent Development
• 7.8 Bexen Medical
  • 7.8.1 Bexen Medical Company Information
  • 7.8.2 Bexen Medical Introduction and Business Overview
  • 7.8.3 Bexen Medical EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Bexen Medical EVA Infusion Bags Product Offerings
  • 7.8.5 Bexen Medical Recent Development
• 7.9 Eraser Medical
  • 7.9.1 Eraser Medical Company Information
  • 7.9.2 Eraser Medical Introduction and Business Overview
  • 7.9.3 Eraser Medical EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Eraser Medical EVA Infusion Bags Product Offerings
  • 7.9.5 Eraser Medical Recent Development
• 7.10 Valmed
  • 7.10.1 Valmed Company Information
  • 7.10.2 Valmed Introduction and Business Overview
  • 7.10.3 Valmed EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Valmed EVA Infusion Bags Product Offerings
  • 7.10.5 Valmed Recent Development
• 7.11 Kapsam Health Products
  • 7.11.1 Kapsam Health Products Company Information
  • 7.11.2 Kapsam Health Products Introduction and Business Overview
  • 7.11.3 Kapsam Health Products EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Kapsam Health Products EVA Infusion Bags Product Offerings
  • 7.11.5 Kapsam Health Products Recent Development
• 7.12 Hemedis
  • 7.12.1 Hemedis Company Information
  • 7.12.2 Hemedis Introduction and Business Overview
  • 7.12.3 Hemedis EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Hemedis EVA Infusion Bags Product Offerings
  • 7.12.5 Hemedis Recent Development
• 7.13 Velfor Group
  • 7.13.1 Velfor Group Company Information
  • 7.13.2 Velfor Group Introduction and Business Overview
  • 7.13.3 Velfor Group EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Velfor Group EVA Infusion Bags Product Offerings
  • 7.13.5 Velfor Group Recent Development
• 7.14 Merit Pharmaceutical
  • 7.14.1 Merit Pharmaceutical Company Information
  • 7.14.2 Merit Pharmaceutical Introduction and Business Overview
  • 7.14.3 Merit Pharmaceutical EVA Infusion Bags Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 Merit Pharmaceutical EVA Infusion Bags Product Offerings
  • 7.14.5 Merit Pharmaceutical Recent Development

8 Industry Chain Analysis

• 8.1 EVA Infusion Bags Industrial Chain
• 8.2 EVA Infusion Bags Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 EVA Infusion Bags Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 EVA Infusion Bags Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer